The Cosmc connection to the Tn antigen in cancer
Open accessThe DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Abstract
The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage in the normal O-glycosylation pathway in which glycans are extended from the common precursor GalNAcα1-O-Ser/Thr (Tn antigen). This precursor is generated in the Golgi apparatus on newly synthesized glycoproteins by a family of polypeptide α-N-acetylgalactosaminyltransferases (ppGalNAcTs) and then extended to the common core 1 O-glycan Galβ1-3GalNAcα1-O-Ser/Thr (T antigen) by a single enzyme termed the T-synthase (core 1 β3-galactosyltransferase or C1GalT). Formation of the active form of the T-synthase requires a unique molecular chaperone termed Cosmc, encoded by Cosmc on the X-chromosome (Xq24 in humans, Xc3 in mice). Cosmc resides in the endoplasmic reticulum (ER) and prevents misfolding, aggregation, and proteasome-dependent degradation of newly synthesized T-synthase. Loss of expression of active T-synthase or Cosmc can lead to expression of the Tn antigen, along with its sialylated version Sialyl Tn antigen as observed in several cancers. Both genetic and epigenetic pathways, in addition to potential metabolic regulation, can result in abnormal expression of the Tn antigen. Engineered expression of the Tn antigen by disruption of either C1GalT (T-syn) or Cosmc in mice is associated with a tremendous range of pathologies and engineered expression of the Tn antigen in mouse embryos leads to embryonic death. Studies indicate that many membrane glycoproteins expressing the Tn antigen and/or truncated O-glycans may be dysfunctional, due to degradation and/or misfolding. Thus, expression of normal O-glycans is associated with health and homeostasis whereas truncation of O-glycans, e.g. the Tn and/or Sialyl Tn antigens is associated with cancer and other pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“have been noted as hallmarks of cancer [6], it is of-”
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679 · cited 1×
“in the United States and worldwide [1,2], despite de-”
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Intra-tumour heterogeneity: a looking glass for cancer?
Marusyk, A., Almendro, V., & Polyak, K. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3261 · Cited by 2,000
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807 · cited 1×
“pression of some mucins is associated with the tumor phenotype [16,121,122].”
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684 · cited 1×
“Among the GI tract mucins, MUC2, which is mainly synthesized and secreted by the goblet cells, is an important mucus layer component to protect epithelial cells [123].”
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<119::aid-ijc17>3.0.co;2-e · Cited by 1,552 · cited 1×
“One of the most useful mouse anti-Tn mAb is an IgM (CA3638, clone 12A8-C7-F5), one of several clones originally developed by Springer and colleagues, and useful in IHC and flow cytometry to detect the Tn antigen [171].”
T and Tn, General Carcinoma Autoantigens
Springer, G. F. (1984) · Science · doi:10.1126/science.6729450 · Cited by 1,009 · cited 1×
“Springer’s group developed specific monoclonal antibodies (mAbs) to the Tn antigen [98] and found that the Tn antigen was commonly expressed in many tumor cells [22].”
Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936 · cited 1×
“MUC2 -deficient ( MUC2 − / − ) mice develop small and large intestinal and rectal tumors, indicating that loss of MUC2 could be an initiating event in intestinal tumorigenesis [124].”
Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., & Tabak, L. A. (2012) · Glycobiology · doi:10.1093/glycob/cwr182 · Cited by 876 · cited 2×
“A large set of approximately 20 different ppGalNAcTs, most of which have a catalytic domain and a separate lectin domain that binds the product of the reaction, leads to efficient modi-fication of specific Ser/Thr residues [43,47].”
Src kinases as therapeutic targets for cancer
Kim, L. C., Song, L., & Haura, E. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.129 · Cited by 700 · cited 1×
“In vivo, the presence of short O-glycans is correlated strongly with increased metastasis and poor survival prognosis in cancer [20,128].”
Schneider, U., Schwenk, H., & Bornkamm, G. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190505 · Cited by 700 · cited 1×
“T cell leukemia [68]; unlike normal T cells, Jurkat cells”
Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1627 · Cited by 612 · cited 1×
“A separate study also found that proper O-glycosylation by the specific ppGalNAcT termed GALNT14 is required for death receptor signaling [127].”
MUC1, The Renaissance Molecule
Gendler, S. J. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011379725811 · Cited by 552 · cited 3×
“Recent studies have shown that for patients with ovarian cancer, evaluating the serum levels of STn in circulating mucins, such as MUC16 (now known to be the CA125 antigen), a mucin produced by ovarian tumors and whose ectodomain is found in blood, may aid in diagnosis, tumor staging, and type [111].”
Mucin‐type O ‐glycans in human colon and breast cancer: glycodynamics and functions
Brockhausen, I. (2006) · EMBO reports · doi:10.1038/sj.embor.7400705 · Cited by 511 · cited 1×
“In vivo, the presence of short O-glycans is correlated strongly with increased metastasis and poor survival prognosis in cancer [20,128].”
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.
Itzkowitz, S., Yuan, M., Montgomery, C. K., Kjeldsen, T., Takahashi, H., Bigbee, W. L., & Kim, Y. S. (1989) · PubMed · Cited by 511
Mucins and mucin binding proteins in colorectal cancer
Byrd, J. C., & Bresalier, R. S. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025815113599 · Cited by 490 · cited 1×
“pression of some mucins is associated with the tumor phenotype [16,121,122].”
Ju, T., & Cummings, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262438199 · Cited by 487 · cited 8×
“…loss of T-synthase was not due to mutation of the T-synthase gene itself, but was rather due to mutation in a single X-linked gene now termed Cosmc [66], that encodes a molecular chaperone found to be required for formation of the active T-synthase and for expression of the protein itself after…”
InfluentialSelf-citationTaylor-Papadimitriou, J., Burchell, J., Miles, D. W., & Dalziel, M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00055-1 · Cited by 465 · cited 2×
“These two antigens have been reported to occur in a majority of human cancers of various types [18–23].”
Eheman, C., Henley, S. J., Ballard‐Barbash, R., Jacobs, E. J., Schymura, M. J., Noone, A., Pan, L., Anderson, R. N., Fulton, J. E., Kohler, B. A., et al. (2012) · Cancer · doi:10.1002/cncr.27514 · Cited by 457 · cited 1×
“Cancer is a leading cause of mortality and morbidity in the United States and worldwide [1,2], despite declines in death rates over the last decade.”
Hakomori, S.-I. (2001) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-1267-7_24 · Cited by 448
Kjeldsen, T., Clausen, H., Hirohashi, S., Ogawa, T., Iijima, H., & Hakomori, S. (1988) · PubMed · Cited by 426
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy
Springer, G. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050144 · Cited by 426 · cited 1×
“It has been estimated that the Tn antigen may be expressed in > 70% of human carcinomas, including colon [100], and others [101–105].”
Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107385108 · Cited by 424
Loss of intestinal core 1–derived O-glycans causes spontaneous colitis in mice
Fu, J., Wei, B., Wen, T., Johansson, M. E. V., Liu, X., Bradford, E., Thomsson, K. A., McGee, S., Mansour, L., Tong, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45538 · Cited by 366 · cited 2×
“By contrast, deletion of the T-synthase , in either whole mice or any tissue, leads to high level expression of the Tn antigen in all tissues [55–57].”
Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor.
Cummings, R. D., Kornfeld, S., Schneider, W. J., Hobgood, K. K., Tolleshaug, H., Brown, M. S., & Goldstein, J. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43802-6 · Cited by 363 · cited 1×
“…may have a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others…”
Self-citationThe Tn Antigen—Structural Simplicity and Biological Complexity
Ju, T., Otto, V. I., & Cummings, R. D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002313 · Cited by 363 · cited 1×
“Since Tn syndrome is accompa-70 nied by a range of phenotypes [78,84], including potential thrombocytopenia, pancytopenia, anemia, and autoantibodies, it is likely that there are many underlying functions of normal extended O-glycans yet to be identified.”
Self-citationIncreased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
An, G., Wei, B., Xia, B., McDaniel, J. M., Ju, T., Cummings, R. D., Braun, J., & Xia, L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061929 · Cited by 352 · cited 1×
“tion of core 3 β3-GlcNAcT in mice leads to a low level expression of the Tn antigen in the GI tract epithelial cells [54].”
Self-citationPredictive biomarkers: a paradigm shift towards personalized cancer medicine
La Thangue, N. B., & Kerr, D. J. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.121 · Cited by 332
Kingsley, D. M., Kozarsky, K. F., Hobble, L., & Krieger, M. (1986) · Cell · doi:10.1016/0092-8674(86)90841-x · Cited by 327
Mucin-type O-glycosylation and its potential use in drug and vaccine development
Tarp, M. A., & Clausen, H. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.09.010 · Cited by 303
Yu, L.-G., Andrews, N., Zhao, Q., McKean, D., Williams, J. F., Connor, L. J., Gerasimenko, O. V., Hilkens, J., Hirabayashi, J., Kasai, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606862200 · Cited by 303 · cited 1×
“It has been proposed that high expression of the disaccharide T antigen in metastatic colon tumor cells enhances their binding to galectin-3 and may promote their adhesion to endothelial cells [126].”
Lakshminarayanan, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., & Boons, G.-J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115166109 · Cited by 301 · cited 1×
“While such vaccine trials are encouraging, the design of the proper immunogens and conjugates continue to be major challenges in the field, as well as understanding the specific antibody recognition of Tn-containing antigens [177,183,202–207].”
Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
Ju, T., Lanneau, G. S., Gautam, T., Wang, Y., Xia, B., Stowell, S. R., Willard, M. T., Wang, W., Xia, J. Y., Zuna, R. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2345 · Cited by 292 · cited 1×
“− Altered expression of Cosmc through acquired mutations [66,136,137] − Altered expression of Cosmc/T-synthase through epigenetic silencing [81,138] − Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140–157] − Altered expres…”
Self-citationCloning and Expression of Human Core 1 β1,3-Galactosyltransferase
Ju, T., Brewer, K., D'Souza, A., Cummings, R. D., & Canfield, W. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109060200 · Cited by 290
Self-citationThe epithelial mucin, MUC1, of milk, mammary gland and other tissues
Patton, S., Gendler, S. J., & Spicer, A. P. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00014-3 · Cited by 285 · cited 3×
“Recent studies have shown that for patients with ovarian cancer, evaluating the serum levels of STn in circulating mucins, such as MUC16 (now known to be the CA125 antigen), a mucin produced by ovarian tumors and whose ectodomain is found in blood, may aid in diagnosis, tumor staging, and type [111].”
Chaperone mutation in Tn syndrome
Ju, T., & Cummings, R. D. (2005) · Nature · doi:10.1038/4371252a · Cited by 271 · cited 1×
“Examination of DNA from blood cells of two male individuals with Tn syndrome revealed that both patients had normal transcripts for the T-synthase, but one patient had a point mutation within Cosmc resulting in a premature stop codon and loss of full-length Cosmc, whereas the other had a point mutation that allowed fu…”
Self-citationSewell, R., Bäckström, M., Dalziel, M., Gschmeissner, S., Karlsson, H., Noll, T., Gätgens, J., Clausen, H., Hansson, G. C., Burchell, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511826200 · Cited by 258
Structures of the O-Glycans on P-selectin Glycoprotein Ligand-1 from HL-60 Cells
Wilkins, P. P., McEver, R. P., & Cummings, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18732 · Cited by 255
Self-citationAberrant glycosylation associated with enzymes as cancer biomarkers
Meany, D. L., & Chan, D. W. (2011) · Clinical Proteomics · doi:10.1186/1559-0275-8-7 · Cited by 247
Location, location, location: new insights into O-GalNAc protein glycosylation
Gill, D. J., Clausen, H., & Bard, F. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.11.004 · Cited by 246 · cited 2×
“sultant accumulation of detectable Tn antigen in the ER [43].”
Koike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402088101 · Cited by 245 · cited 1×
“Interestingly, hypoxia can result in altered expression of the transporter for UDP-Gal, as seen for up-regulation of UGT-1 transcripts in SW480 colon carcinoma cells upon induction of hypoxia and in cancer tissues from patients [167].”
Fu, J., Gerhardt, H., McDaniel, J. M., Xia, B., Liu, X., Ivanciu, L., Ny, A., Hermans, K., Silasi-Mansat, R., McGee, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36077 · Cited by 242
Self-citationHansen, J. E., Lund, O., Engelbrecht, J., Bohr, H., Nielsen, J. O., Hansen, J. E. S., & Brunak, S. (1995) · Biochemical Journal · doi:10.1042/bj3080801 · Cited by 241
Röttger, S., White, J., Wandall, H. H., Olivo, J.-C., Stark, A., Bennett, E. P., Whitehouse, C., Berger, E. G., Clausen, H., & Nilsson, T. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.1.45 · Cited by 239
a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
Huang, Z.-H., Shi, L., Ma, J.-W., Sun, Z.-Y., Cai, H., Chen, Y.-X., Zhao, Y.-F., & Li, Y.-M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211725s · Cited by 223
A Novel Glycosulfopeptide Binds to P-selectin and Inhibits Leukocyte Adhesion to P-selectin
Leppänen, A., Mehta, P., Ouyang, Y.-B., Ju, T., Helin, J., Moore, K. L., van Die, I., Canfield, W. M., McEver, R. P., & Cummings, R. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24838 · Cited by 216 · cited 1×
“…a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39,41].”
Self-citationCosmc is an essential chaperone for correct protein O-glycosylation
Wang, Y., Ju, T., Ding, X., Xia, B., Wang, W., Xia, L., He, M., & Cummings, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914004107 · Cited by 212 · cited 1×
“In embryonic stem (ES) cells lacking Cosmc we examined the structures of glycans expressed by the cells and the ability of the cells to grow in culture [77].”
Self-citationExpression of mucin antigens in human cancers and its relationship with malignancy potential
Yonezawa, S., & Sato, E. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb03713.x · Cited by 206 · cited 1×
“Some glycoproteins may have a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39…”
Clinical aspects of altered glycosylation of glycoproteins in cancer
Orntoft, T. F., & Vestergaard, E. M. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2<362::aid-elps362>3.0.co;2-v · Cited by 205
Regulation of O -glycosylation through Golgi-to-ER relocation of initiation enzymes
Gill, D. J., Chia, J., Senewiratne, J., & Bard, F. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003055 · Cited by 204 · cited 1×
“cells can lead to relocalization of some ppGalNAcTs from the Golgi to the ER [59], resulting in higher den-”
Julien, S., Adriaenssens, E., Ottenberg, K., Furlan, A., Courtand, G., Vercoutter-Edouart, A.-S., Hanisch, F.-G., Delannoy, P., & Le Bourhis, X. (2006) · Glycobiology · doi:10.1093/glycob/cwj033 · Cited by 204 · cited 1×
“STn antigen expression is observed in many epithelial cancers, and its expression correlates with enhanced expression of ST6GalNAc-I [108] and elevated serum levels of STn antigen are associated with poor prognosis [109,110].”
Hirohashi, S., Clausen, H., Yamada, T., Shimosato, Y., & Hakomori, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7039 · Cited by 197 · cited 1×
“However, many of these different mAbs to the Tn antigen lack specificity and many cross-react with other GalNAc-containing glycans, such as blood group A [172] while some of these mAbs appear to be more specific [174].”
Kellokumpu, S., Sormunen, R., & Kellokumpu, I. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02535-8 · Cited by 194 · cited 1×
“…sugars, ectopic expression of unusual glycoproteins, altered routing of glycoproteins in the ER/Golgi axis in tumor cells, GOLPH3-dependent alterations in vesicular and Golgi transport and glycosylation pathways [133], altered Golgi pH and altered glycosyltransferase organization [134,135].”
Davis, C. G., Elhammer, A., Russell, D. W., Schneider, W. J., Kornfeld, S., Brown, M. S., & Goldstein, J. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35862-3 · Cited by 192
Recent insights into the biological roles of mucin-type O-glycosylation
Tian, E., & Ten Hagen, K. G. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-008-9162-4 · Cited by 191
A Family of Human β3-Galactosyltransferases
Amado, M., Almeida, R., Carneiro, F., Levery, S. B., Holmes, E. H., Nomoto, M., Hollingsworth, M. A., Hassan, H., Schwientek, T., Nielsen, P. A., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12770 · Cited by 191 · cited 1×
“…antigen product of these ppGalNAcT reactions would exist in a large family, because the pp-GalNAcT family was known to be large and the general β 3-galactosyltransferase family, to which the T-synthase(s) was expected to belong, was known to be comprised of a large number of related genes [62,63].”
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/54.2.335 · Cited by 188
Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1–derived O-glycans
Xia, L., Ju, T., Westmuckett, A., An, G., Ivanciu, L., McDaniel, J. M., Lupu, F., Cummings, R. D., & McEver, R. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200311112 · Cited by 187 · cited 2×
“By contrast, deletion of the T-synthase , in either whole mice or any tissue, leads to high level expression of the Tn antigen in all tissues [55–57].”
Self-citationIdentification of Two Glycoforms of the MUC5B Mucin in Human Respiratory Mucus
Thornton, D. J., Howard, M., Khan, N., & Sheehan, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9561 · Cited by 183 · cited 1×
“Some glycoproteins may have a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39…”
Park, J.-H., Nishidate, T., Kijima, K., Ohashi, T., Takegawa, K., Fujikane, T., Hirata, K., Nakamura, Y., & Katagiri, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3911 · Cited by 175
Slovin, S. F., Ragupathi, G., Musselli, C., Olkiewicz, K., Verbel, D., Kuduk, S. D., Schwarz, J. B., Sames, D., Danishefsky, S., Livingston, P. O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.112 · Cited by 171 · cited 1×
“More recent studies in this direction have explored specific defined synthetic conjugates [175] containing glycopeptides with one or more GalNAc α 1-O-Ser/Thr modifications [199–201].”
Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis
Xia, B., Royall, J. A., Damera, G., Sachdev, G. P., & Cummings, R. D. (2005) · Glycobiology · doi:10.1093/glycob/cwi061 · Cited by 171 · cited 1×
“…a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39,41].”
Self-citationPeng, R.-Q., Wan, H.-Y., Li, H.-F., Liu, M., Li, X., & Tang, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337642 · Cited by 165
Hassan, H., Reis, C. A., Bennett, E. P., Mirgorodskaya, E., Roepstorff, P., Hollingsworth, M. A., Burchell, J., Taylor-Papadimitriou, J., & Clausen, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005783200 · Cited by 164 · cited 1×
“Loss of the lectin domain activity of the ppGalNAcTs leads to loss of functional efficiency [48,49].”
Kobayashi, H., Terao, T., & Kawashima, Y. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.95 · Cited by 160 · cited 1×
“STn antigen expression is observed in many epithelial cancers, and its expression correlates with enhanced expression of ST6GalNAc-I [108] and elevated serum levels of STn antigen are associated with poor prognosis [109,110].”
A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific Antigen
Schietinger, A., Philip, M., Yoshida, B. A., Azadi, P., Liu, H., Meredith, S. C., & Schreiber, H. (2006) · Science · doi:10.1126/science.1129200 · Cited by 160 · cited 2×
“Murine tumors, such as mouse fibrosarcoma, and neuroblastoma also have specific mutations in Cosmc [137].”
Kozarsky, K., Kingsley, D., & Krieger, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4335 · Cited by 159
Sabbatini, P. J., Ragupathi, G., Hood, C., Aghajanian, C. A., Juretzka, M., Iasonos, A., Hensley, M. L., Spassova, M. K., Ouerfelli, O., Spriggs, D. R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2949 · Cited by 155 · cited 1×
“More recent studies in this direction have explored specific defined synthetic conjugates [175] containing glycopeptides with one or more GalNAc α 1-O-Ser/Thr modifications [199–201].”
Altered Glycosylation in Tumours Focused to Cancer Diagnosis
Peracaula, R., Barrabés, S., Sarrats, A., Rudd, P. M., & de Llorens, R. (2008) · Disease Markers · doi:10.1155/2008/797629 · Cited by 155 · cited 1×
“While many cellular changes have been noted as hallmarks of cancer [6], it is often not acknowledged that a change in glycosylation of proteins/lipids is also a hallmark of cancer [7–10].”
Rivinoja, A., Hassinen, A., Kokkonen, N., Kauppila, A., & Kellokumpu, S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21744 · Cited by 152
Mechanisms of cancer-associated glycosylation changes
Dall'Olio, F. (2012) · Frontiers in Bioscience · doi:10.2741/3951 · Cited by 152
Guda, K., Moinova, H., He, J., Jamison, O., Ravi, L., Natale, L., Lutterbaugh, J., Lawrence, E., Lewis, S., Willson, J. K. V., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901454106 · Cited by 145 · cited 1×
“Somatic and germ-line mutations in GALNT12 have been identified in individuals with colon cancer [131].”
ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
Reis, C. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/e345 · Cited by 142 · cited 3×
“STn antigen expression is observed in many epithelial cancers, and its expression correlates with enhanced expression of ST6GalNAc-I [108] and elevated serum levels of STn antigen are associated with poor prognosis [109,110].”
Ikehara, Y., Kojima, N., Kurosawa, N., Kudo, T., Kono, M., Nishihara, S., Issiki, S., Morozumi, K., Itzkowitz, S., Tsuda, T., et al. (1999) · Glycobiology · doi:10.1093/glycob/9.11.1213 · Cited by 139
O‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer
VAVASSEUR, F., DOLE, K., YANG, J., MATTA, K. L., MYERSCOUGH, N., CORFIELD, A., PARASKEVA, C., & BROCKHAUSEN, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18880.x · Cited by 136 · cited 1×
“While the T-synthase and generation of core 1 O-glycans are considered ubiquitous in mammalian cells, the formation of the alternative core 3 O-glycans, which also arise from the Tn antigen precursor [52,53], appears to be limited to the GI tract epithelia, where the core 3 β3-GlcNAcT (β3GnT6) is expressed in a restri…”
Ju, T., Aryal, R. P., Stowell, C. J., & Cummings, R. D. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711151 · Cited by 134
Self-citationTakahashi, H. K., Metoki, R., & Hakomori, S. (1988) · PubMed · Cited by 133
Hubert, P., Heitzmann, A., Viel, S., Nicolas, A., Sastre‐Garau, X., Oppezzo, P., Pritsch, O., Osinaga, E., & Amigorena, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4222 · Cited by 132 · cited 1×
“[182] investigated the mechanism of action of a Tn antigen-specific chimeric mAb (Chi-Tn) and found that Chi-Tn showed no direct toxicity against carcinoma cell lines in vitro, but induced the rejection of a murine breast tumor in 80–100% of immunocompetent mice through in vivo ADCC mediated by macrophages and neutrop…”
Hassinen, A., Pujol, F. M., Kokkonen, N., Pieters, C., Kihlström, M., Korhonen, K., & Kellokumpu, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277681 · Cited by 131 · cited 1×
“…sugars, ectopic expression of unusual glycoproteins, altered routing of glycoproteins in the ER/Golgi axis in tumor cells, GOLPH3-dependent alterations in vesicular and Golgi transport and glycosylation pathways [133], altered Golgi pH and altered glycosyltransferase organization [134,135].”
Wu, Y., Liu, C., Hu, R., Huang, M.-J., Lee, J., Chen, C., Huang, J. C., Lai, H., Lee, P., Hsu, W., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1161 · Cited by 127
Expression of Tn, sialosyl Tn, and T antigens in human pancreas
Itzkowitz, S. H., Kjeldsen, T., Friera, A. M., Hakomori, S., Yang, U.-S., & Kim, Y. S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90671-7 · Cited by 126
Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations
Ichikawa, S., Baujat, G., Seyahi, A., Garoufali, A., Imel, E. A., Padgett, L. R., Austin, A. M., Sorenson, A. H., Péjin, Z., Topouchian, V., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33337 · Cited by 123
Dausset, J. B., Moullec, J., & Bernard, J. (1959) · Blood · doi:10.1182/blood.v14.10.1079.1079 · Cited by 119 · cited 2×
“Moreau et al [86,88] named the antigen they identified as the “T antigen nouvelle” or Tn antigen in recognition of its potential relationship to the T antigen.”
Orntoft, T. F., Harving, N., & Langkilde, N. C. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450416 · Cited by 119 · cited 1×
“Similarly, Orntoft et al. [113] reported no expression of Tn in adult colorectal tissue, but found accumulation in colon carcinoma.”
Biosynthesis of truncated O-glycans in the T cell line Jurkat. Localization of O-glycan initiation.
Piller, V., Piller, F., & Fukuda, M. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38842-8 · Cited by 118 · cited 1×
“In studying the activity of the T-synthase we found that the enzyme was very poorly expressed at the protein level in the commonly studied Jurkat cell line [66], which was consistent with an earlier observation that Jurkat cells display the Tn antigen [67].”
Purification, Characterization, and Subunit Structure of Rat Core 1 β1,3-Galactosyltransferase
Ju, T., Cummings, R. D., & Canfield, W. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109056200 · Cited by 117
Self-citationBerger, E. G. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00069-1 · Cited by 115
Molecular Basis of Tn‐Polyagglutinability1
Wolfgang, D. A. H. R., UHLENBRUCK, G., Gunson, H. H., & HART, M. V. D. (1975) · Vox Sanguinis · doi:10.1111/j.1423-0410.1975.tb00475.x · Cited by 113
Cryptic A‐Like Receptor Sites in Human Erythrocyte Glycoproteins: Proposed Nature of Tn‐Antigen
Wolfgang, D. A. H. R., Uhlenbruck, G., & Bird, G. W. G. (1974) · Vox Sanguinis · doi:10.1111/j.1423-0410.1974.tb02386.x · Cited by 112 · cited 1×
“However, it was subsequently shown that the Tn antigen is GalNAcα1O-Ser/Thr [89,90].”
Kumamoto, K., Goto, Y., Sekikawa, K., Takenoshita, S., Ishida, N., Kawakita, M., & Kannagi, R. (2001) · PubMed · Cited by 112
Taylor‐Papadimitriou, J., & Epenetos, A. A. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90121-x · Cited by 111 · cited 1×
“Tn and STn antigens are also highly expressed in human breast cancers [106,107], where”
Almaraz, R. T., Tian, Y., Bhattarcharya, R., Tan, E., Chen, S.-H., Dallas, M. R., Chen, L., Zhang, Z., Zhang, H., Konstantopoulos, K., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017558 · Cited by 109
White, R. L., Schwartzentruber, D. J., Guleria, A. S., Macfarlane, M., White, D. E., Tucker, E. E., & Rosenberg, S. A. (1994) · Cancer · doi:10.1002/1097-0142(19941215)74:12<3135::aid-cncr2820741212>3.0.co;2-8 · Cited by 108
Park, J.-H., Katagiri, T., Chung, S., Kijima, K., & Nakamura, Y. (2011) · Neoplasia · doi:10.1593/neo.101440 · Cited by 105
Adami, H., Bergström, R., & Hansen, J. (1985) · Cancer · doi:10.1002/1097-0142(19850201)55:3<643::aid-cncr2820550328>3.0.co;2-l · Cited by 105
Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps.
Itzkowitz, S. H., Bloom, E. J., Lau, T. S., & Kim, Y. S. (1992) · Gut · doi:10.1136/gut.33.4.518 · Cited by 104 · cited 1×
“[119] examined 103 colorectal polyps for expression of Tn/STn and found that Tn antigen was expressed by all of the polyps, whereas STn, on the other hand was expressed weakly in 7 of 24 hyperplastic polyps.”
Liu, W.-J., Ramachandran, V., Kang, J., Kishimoto, T. K., Cummings, R. D., & McEver, R. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7078 · Cited by 103 · cited 1×
“…a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39,41].”
Self-citationZhang, H., Guo, T., Li, X., Datta, A., Park, J. E., Yang, J., Lim, S. K., Tam, J. P., & Sze, S. K. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900314-mcp200 · Cited by 98 · cited 1×
“genome are glycosylated [17], it is likely that changes”
Kiyohara, M., Nakatomi, T., Kurihara, S., Fushinobu, S., Suzuki, H., Tanaka, T., Shoda, S.-I., Kitaoka, M., Katayama, T., Yamamoto, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277384 · Cited by 97
Yang, K., Popova, N. V., Yang, W. C., Lozonschi, I., Tadesse, S., Kent, S., Bancroft, L., Matise, I., Cormier, R. T., Scherer, S. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0598 · Cited by 96 · cited 1×
“Interestingly, tumors from MUC2 − / − mice can arise independently from alterations of Wnt/ β -catenin/Tcf4 signaling, through an inflammation-related pathway that is distinct from and can complement mechanisms of tumorigenesis in Apc + / − mice [125].”
Blood group MN specific substances and precursors in normal and malignant human breast tissues
Springer, G. F., Desai, P. R., & Banatwala, I. (1974) · Die Naturwissenschaften · doi:10.1007/bf00597216 · Cited by 94 · cited 1×
“The association of the Tn antigen with tumor cells was first noted by Springer and colleagues [96,97], which was an observation that evolved from studies on the human MN blood group antigens.”
Platelet biogenesis and functions require correct protein O-glycosylation
Wang, Y., Jobe, S. M., Ding, X., Choo, H. J., Archer, D. R., Mi, R., Ju, T., & Cummings, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208253109 · Cited by 94 · cited 1×
“Abnormal expression of such O-glycans is often associated with dysfunctional activity of glycoproteins, such as altered stability, turnover, or expression, as recently seen in murine platelets expressing truncated O-glycans [42].”
Self-citationGolgi N-Glycosyltransferases Form Both Homo- and Heterodimeric Enzyme Complexes in Live Cells
Hassinen, A., Rivinoja, A., Kauppila, A., & Kellokumpu, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103184 · Cited by 93 · cited 1×
“− Altered expression of Cosmc through acquired mutations [66,136,137] − Altered expression of Cosmc/T-synthase through epigenetic silencing [81,138] − Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140–157] − Altered expres…”
Shibao, K., Izumi, H., Nakayama, Y., Ohta, R., Nagata, N., Nomoto, M., Matsuo, K., Yamada, Y., Kitazato, K., Itoh, H., et al. (2002) · Cancer · doi:10.1002/cncr.10423 · Cited by 93
Yamada, K., Kobayashi, N., Ikeda, T., Suzuki, Y., Tsuge, T., Horikoshi, S., Emancipator, S. N., & Tomino, Y. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq325 · Cited by 91
Medial Golgi but Not Late Golgi Glycosyltransferases Exist as High Molecular Weight Complexes
Opat, A. S., Houghton, F., & Gleeson, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11836 · Cited by 90 · cited 1×
“− Altered expression of Cosmc through acquired mutations [66,136,137] − Altered expression of Cosmc/T-synthase through epigenetic silencing [81,138] − Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140–157] − Altered expres…”
Antibody recognition of a unique tumor-specific glycopeptide antigen
Brooks, C. L., Schietinger, A., Borisova, S. N., Kufer, P., Okon, M., Hirama, T., MacKenzie, C. R., Wang, L., Schreiber, H. W., & Evans, S. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915176107 · Cited by 89
Reddish, M. A., Jackson, L., Koganty, R. R., Qiu, D., Hong, W., & Longenecker, B. M. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018576224062 · Cited by 88
Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma
Schumacher, U., Higgs, D., Loizidou, M., Pickering, R. M., Leathem, A. J., & Taylor, I. (1994) · Cancer · doi:10.1002/1097-0142(19941215)74:12<3104::aid-cncr2820741207>3.0.co;2-0 · Cited by 87
A monoclonal antibody directed to Tn antigen
Numata, Y., Nakada, H., Fukui, S., Kitagawa, H., Ozaki, K., Inoue, M., Kawasaki, T., Funakoshi, I., & Yamashina, I. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90488-9 · Cited by 86
Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated Oncogenesis
Scott, K. L., & Chin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1695 · Cited by 86 · cited 2×
“terations in vesicular and Golgi transport and glycosylation pathways [133], altered Golgi pH and altered”
A polyvalent vaccine for high-risk prostate patients: “are more antigens better?”
Slovin, S. F., Ragupathi, G., Fernandez, C., Diani, M., Jefferson, M. P., Wilton, A. S., Kelly, W. K., Morris, M. J., Solit, D. B., Clausen, H., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0335-y · Cited by 85
Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth
Taniuchi, K., Cerny, R. L., Tanouchi, A., Kohno, K., Kotani, N., Honke, K., Saibara, T., & Hollingsworth, M. A. (2011) · Oncogene · doi:10.1038/onc.2011.194 · Cited by 84
Julien, S., Krzewinski‐Recchi, M., Harduin‐Lepers, A., Gouyer, V., Huet, G., Bourhis, X. L., & Delannoy, P. (2001) · Glycoconjugate Journal · doi:10.1023/a:1022200525695 · Cited by 83
Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera
Springer, G. F., Taylor, C. R., Howard, D. R., Tegtmeyer, H., Desai, P. R., Murthy, S. M., Felder, B., & Scanlon, E. F. (1985) · Cancer · Cited by 83
Kolbinger, F., Streiff, M. B., & Katopodis, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.433 · Cited by 81 · cited 1×
“It was anticipated that the core 1 β3-galactosyltransferase(s) that modify the Tn antigen product of these ppGalNAcT reactions would exist in a large family, because the ppGalNAcT family was known to be large and the general β3-galactosyltransferase family, to which the Tsynthase(s) was expected to belong, was known t…”
Yang, I. B. J., Lehotay, M., Ogata, S., & Itzkowitz, S. H. (2001) · Biological Chemistry · doi:10.1515/bc.2001.029 · Cited by 79 · cited 1×
“…of core 1 O-glycans are considered ubiquitous in mammalian cells, the formation of the alternative core 3 O-glycans, which also arise from the Tn antigen precursor [52,53], appears to be limited to the GI tract epithelia, where the core 3 β 3-GlcNAcT ( β 3GnT6 ) is expressed in a restricted manner.”
Enzymatic basis for sialyl-Tn expression in human colon cancer cells
Brockhausen, I., Yang, J., Dickinson, N., Ogata, S., & Itzkowitz, S. H. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006967910803 · Cited by 78 · cited 2×
“These two antigens have been reported to occur in a majority of human cancers of various types [18–23].”
Li, Z., Yamada, S., Inenaga, S., Imamura, T., Wu, Y., Wang, K.-Y., Shimajiri, S., Nakano, R., Izumi, H., Kohno, K., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.166 · Cited by 76
Li, Q., Anver, M. R., Butcher, D. O., & Gildersleeve, J. C. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0934 · Cited by 75 · cited 1×
“More recent studies in this direction have explored specific defined synthetic conjugates [175] containing glycopeptides with one or more GalNAc α 1-O-Ser/Thr modifications [199–201].”
The Endoplasmic Reticulum Chaperone Cosmc Directly Promotes in Vitro Folding of T-synthase
Aryal, R. P., Ju, T., & Cummings, R. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065169 · Cited by 75 · cited 2×
“Interestingly, although Cosmc has an ATP binding activity [69,76], ATP does not affect these interactions in vitro ; thus, at this time the potential role of ATP, if any, in the function of Cosmc is unknown.”
Self-citationCartron, J., & Nurden, A. T. (1979) · Nature · doi:10.1038/282621a0 · Cited by 74
Müller, R., Hülsmeier, A. J., Altmann, F., Hagen, K. G. T., Tiemeyer, M., & Hennet, T. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04838.x · Cited by 73
Kudo, T., Iwai, T., Kubota, T., Iwasaki, H., Takayma, Y., Hiruma, T., Inaba, N., Zhang, Y., Gotoh, M., Togayachi, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205839200 · Cited by 72
Thurnher, M., Rusconi, S., & Berger, E. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116434 · Cited by 70 · cited 1×
“…− Altered expression of Cosmc through acquired mutations [66,136,137] − Altered expression of Cosmc/T-synthase through epigenetic silencing [81,138] − Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs…”
Brockhausen, I., Moeller, G., Merz, G., Adermann, K., & Paulsen, H. M. (1990) · Biochemistry · doi:10.1021/bi00496a008 · Cited by 70 · cited 1×
“These studies reported that the enzyme activity was present in a variety of tissues and efficiently utilized glycopeptide acceptors with the Tn antigen [61], as well as the simple acceptor GalNAc α 1-benzyl [60].”
Berois, N., Mazal, D., Ubillos, L., Trajtenberg, F., Nicolas, A., Sastre-Garau, X., Magdelenat, H., & Osinaga, E. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6783.2005 · Cited by 66
Glycoproteomics-Based Identification of Cancer Biomarkers
Kim, E. H., & Misek, D. E. (2011) · International Journal of Proteomics · doi:10.1155/2011/601937 · Cited by 63
Freire, T., Berois, N., Sóñora, C., Varangot, M., Barrios, E., & Osinaga, E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21959 · Cited by 63
Expression of Tn and Sialyl-Tn Antigens in Tumor Tissues of the Ovary
Inoue, M., Ton, S., Ogawa, H., & Tanizawa, O. (1991) · American Journal of Clinical Pathology · doi:10.1093/ajcp/96.6.711 · Cited by 63
Rutledge, E., Root, B., Lucas, J., & Enns, C. (1994) · Blood · doi:10.1182/blood.v83.2.580.580 · Cited by 62
Wu, C., Guo, X., Wang, W., Wang, Y., Shan, Y., Zhang, B., Song, W., Ma, S., Ge, J., Deng, H., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-123 · Cited by 62
Self-citationExpression of tag‐72 in normal colon, transitional mucosa, and colon cancer
Xu, M., Real, F. X., Welt, S., Schüssler, M. H., Oettgen, H. F., & Old, L. J. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440607 · Cited by 61 · cited 1×
“Human tumor-associated glycoprotein-72 (TAG-72) is a carcinoma mucin molecule expressed in colon [184,185], breast [186], pancreatic [187], ovarian [188], lung, and gastric cancers [189].”
Marcos, N. T., Cruz, A., Santos‐Silva, F., Almeida, R., David, L., Mandel, U., Clausen, H., von Mensdorff‐Pouilly, S., & Reis, C. A. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100607 · Cited by 60
TERASAWA, K., Furumoto, H., Kamada, M., & Aono, T. (1996) · PubMed · Cited by 59
Identification of the O-linked glycosylation site of the human transferrin receptor
Hayes, G. R., Enns, C. A., & Lucas, J. J. (1992) · Glycobiology · doi:10.1093/glycob/2.4.355 · Cited by 59
Deciphering Structural Elements of Mucin Glycoprotein Recognition
Borgert, A., Heimburg-Molinaro, J., Song, X., Lasanajak, Y., Ju, T., Liu, M., Thompson, P., Ragupathi, G., Barany, G., Smith, D. F., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300076s · Cited by 58 · cited 1×
“This mAb against the Tn antigen has been used to detect Tn antigen and shown to be relatively specific for glycopeptides expressing multiple Tn antigens [13, 177,178].”
Self-citationKabuß, R., Ashikov, A., Oelmann, S., Gerardy‐Schahn, R., & Bakker, H. (2005) · Glycobiology · doi:10.1093/glycob/cwi085 · Cited by 55
Cao, Y., Merling, A., Karsten, U. R., Goletz, S., Punzel, M., Kraft, R., Butschak, G., & Schwartz‐Albiez, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23493 · Cited by 54 · cited 1×
“The Tn, STn, and T antigens are designated CD175, CD175s, and CD176, respectively [91–94].”
Akita, K., Yoshida, S., Ikehara, Y., Shirakawa, S., Toda, M., Inoue, M., Kitawaki, J., Nakanishi, H., Narimatsu, H., & Nakada, H. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182473292 · Cited by 54 · cited 2×
“Recent studies have shown that for patients with ovarian cancer, evaluating the serum levels of STn in circulating mucins, such as MUC16 (now known to be the CA125 antigen), a mucin produced by ovarian tumors and whose ectodomain is found in blood, may aid in diagnosis, tumor staging, and type [111].”
Freire, T., Lo-Man, R., Bay, S., & Leclerc, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209742 · Cited by 53
The Thomsen-Friedenreich (TF) Receptor: An Old History with New Mystery
Uhlenbruck, G. (1981) · Immunological Communications · doi:10.3109/08820138109093459 · Cited by 53 · cited 1×
“This enzyme transfers Gal from the donor UDP-Gal to synthesize the core 1 disaccharide Galβ1-3GalNAcα1-O-Ser/Thr, which is also called the T antigen (and is also sometimes called the Thomsen-Friedenreich or TF antigen) [50,51].”
Jass, J. R., Allison, L. M. C., & Edgar, S. G. (1994) · Pathology · doi:10.1080/00313029400169112 · Cited by 53
Brooks, S. A., Carter, T. M., Bennett, E., Clausen, H., & Mandel, U. (2007) · Acta Histochemica · doi:10.1016/j.acthis.2007.02.009 · Cited by 52 · cited 1×
“…− Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140 –157 Other less specific factors that could also impact expression of other classes of glycans include altered expression of nucleotide sugar…”
New mutations in C1GALT1C1 in individuals with Tn positive phenotype
Crew, V. K., Singleton, B. K., Green, C. A., Parsons, S. F., Daniels, G. L., & Anstee, D. J. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07215.x · Cited by 49 · cited 1×
“Other laboratories have confirmed these findings and identified additional patients with mutations in Cosmc [83,95].”
Tenno, M., Saeki, A., Kézdy, F. J., Elhammer, Å. P., & Kurosaka, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207369200 · Cited by 49 · cited 1×
“Loss of the lectin domain activity of the ppGalNAcTs leads to loss of functional efficiency [48,49].”
Mitchell, B., & Schumacher, U. (1999) · PubMed · doi:10.14670/hh-14.217 · Cited by 48 · cited 1×
“In some studies HPA reactivity was equal or superior to other classical markers of the metastatic potential of human colon cancer [115].”
Inherited deleterious variants inGALNT12are associated with CRC susceptibility
Clarke, E., Green, R. C., Green, J. S., Mahoney, K., Parfrey, P. S., Younghusband, H. B., & Woods, M. O. (2012) · Human Mutation · doi:10.1002/humu.22088 · Cited by 48 · cited 1×
“For example, inherited deleterious variants in GALNT12 are associated with susceptibility to colorectal cancer [129], consistent with earlier studies that expression of GALNT12 seems to be a negative marker especially of metastatic gastric and colorectal cancer [130].”
Brockhausen, I., Möller, G., Pollex-Krüger, A., Rutz, V., Paulsen, H., & Matta, K. L. (1992) · Biochemistry and Cell Biology · doi:10.1139/o92-015 · Cited by 48
Identification of core 1 O-glycan T-synthase from Caenorhabditis elegans
Ju, T., Zheng, Q., & Cummings, R. D. (2006) · Glycobiology · doi:10.1093/glycob/cwl008 · Cited by 48 · cited 1×
“Cosmc itself is expressed by all vertebrates from zebrafish to humans but is not found in invertebrates [65,73], although invertebrates have one or more genes encoding enzymes with core 1 β 3-galactosyltransferase activity [65,73,74].”
Self-citationYamamoto, S., Nakamori, S., Tsujie, M., Takahashi, Y., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Tomita, Y., Hoshida, Y., et al. (2003) · Pathobiology · doi:10.1159/000072957 · Cited by 47
A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity
Welinder, C., Baldetorp, B., Borrebaeck, C. A. K., Fredlund, B.-M., & Jansson, B. (2011) · Glycobiology · doi:10.1093/glycob/cwr048 · Cited by 47 · cited 1×
“[183] reported that the murine anti-Tn antibody displayed anti-tumor activity in xenograft SCID mice.”
The MUC gene family: their role in the diagnosis and prognosis of gastric cancer.
Senapati, S., Sharma, P., Bafna, S., Roy, H. K., & Batra, S. K. (2008) · PubMed · doi:10.14670/hh-23.1541 · Cited by 44 · cited 1×
“pression of some mucins is associated with the tumor phenotype [16,121,122].”
Meyts, E. R., Poll, S. N., Goukasian, I., Jeanneau, C., Herlihy, A. S., Bennett, E., Skakkebæk, N. E., Clausen, H., Giwercman, A., & Mandel, U. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0478-4 · Cited by 43
Vázquez-Martín, C., Cuevas, E., Gil-Martín, E., & Fernández-Briera, A. (2004) · Oncology · doi:10.1159/000081003 · Cited by 43
Abdel-Aal, A.-B. M., El-Naggar, D., Zaman, M., Batzloff, M., & Toth, I. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300822g · Cited by 41
Końska, G., Guerry, M., Caldefie‐Chezet, F., de Latour, M., & Guillot, J. (2006) · Oncology Reports · doi:10.3892/or.15.2.305 · Cited by 41 · cited 1×
“Tn and STn antigens are also highly expressed in human breast cancers [106,107], where”
Guo, J., Chen, H.-L., Wang, G., Zhang, Y.-K., & Narimatsu, H. (2004) · Oncology · doi:10.1159/000081328 · Cited by 41 · cited 2×
“…[81,138] − Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140 –157 Other less specific factors that could also impact expression of other classes of glycans include altered expression of nucleotide…”
Presence of O-linked oligosaccharide on a threonine residue in the human transferrin receptor
Do, S., & Cummings, R. D. (1992) · Glycobiology · doi:10.1093/glycob/2.4.345 · Cited by 41 · cited 1×
“Some glycoproteins may have a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38],…”
Self-citationAndo, H., Matsushita, T., Wakitani, M., Sato, T., Kodama-Nishida, S., Shibata, K., Shitara, K., & Ohta, S. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1739 · Cited by 41 · cited 1×
“Studies evaluating anti-Tn mAbs include the use of MLS128 to inhibit the growth of colon and breast cancer cell lines [179], the use of single-chain antibody fragments (scFv) fused to an antibody constant region (Fc) having antibodydependent cellular cytotoxicity (ADCC) activity [180], and the use of mouse-human chime…”
In vivo glycosylation of mucin tandem repeats
Silverman, H. S., Parry, S., Sutton‐Smith, M., Burdick, M. D., McDermott, K., Reid, C. J., Batra, S. K., Morris, H. R., Hollingsworth, M. A., Dell, A., et al. (2001) · Glycobiology · doi:10.1093/glycob/11.6.459 · Cited by 41 · cited 1×
“…a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38], MUC5AC, and others [38,39,41].”
Springer, G. F., Desai, P. R., Tegtmeyer, H., Spencer, B. D., & Scanlon, E. F. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb44029.x · Cited by 39 · cited 1×
“Anti-tumor efficacy was evaluated and some positive results were observed [198].”
Kobayashi, H., Terao, T., & Kawashima, Y. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.6.983 · Cited by 38 · cited 1×
“STn antigen expression is observed in many epithelial cancers, and its expression correlates with enhanced expression of ST6GalNAc-I [108] and elevated serum levels of STn antigen are associated with poor prognosis [109,110].”
Cartron, J. P., Andreu, G., Cartron, J., Salmon, C., & Bird, G. W. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90197-6 · Cited by 38
Kohsaki, T., Nishimori, I., Nakayama, H., Miyazaki, E., Enzan, H., Nomoto, M., Hollingsworth, M. A., & Onishi, S. (2000) · Journal of Gastroenterology · doi:10.1007/s005350070021 · Cited by 37 · cited 1×
“…Altered expression of Cosmc/T-synthase through signaling pathways [139] − Altered expression or localization of the ppGalNAcTs [59,112,130–132,140 –157 Other less specific factors that could also impact expression of other classes of glycans include altered expression of nucleotide sugar…”
Matsumoto, Y., Zhang, Q., Akita, K., Nakada, H., Hamamura, K., Tokuda, N., Tsuchida, A., Matsubara, T., Hori, T., Okajima, T., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.086 · Cited by 37 · cited 3×
“Transfection of cells with UGT-1 cDNA also was previously shown to enhance expression of sialyl Lewis a antigen [168]. ppGalNAc-T13 expression is associated with induction of Tn antigen in specific locations as a trivalent (trimeric) structure on Syndecan-1 [141].”
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells
Thurnher, M., Wagner, E., Clausen, H., Mechtler, K., Rusconi, S., Dinter, A., Birnstiel, M. L., Berger, E. G., & Cotten, M. L. (1994) · Glycobiology · doi:10.1093/glycob/4.4.429 · Cited by 37 · cited 1×
“Several groups have now developed or used anti-Tn and STn mAbs in multiple studies [136,170–176].”
Glycosylation effects on cancer development
Hakomori, S., & Cummings, R. D. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9448-4 · Cited by 36
Self-citationSingle‐Chain Antibodies in Pancreatic Cancer
Colcher, D. M., Pavlínková, G., Beresford, G., Booth, B. J. M., & Batra, S. K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09531.x · Cited by 36 · cited 1×
“Human tumor-associated glycoprotein-72 (TAG-72) is a carcinoma mucin molecule expressed in colon [184,185], breast [186], pancreatic [187], ovarian [188], lung, and gastric cancers [189].”
MOREAU, R., Dausset, J. B., Bernard, J., & Moullec, J. (1957) · PubMed · Cited by 36
Aryal, R. P., Ju, T., & Cummings, R. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312587 · Cited by 34 · cited 3×
“The overall model, first put forward in 2002 [66] and further refined in 2008 [69] and 2012 [75] is depicted in Fig.”
Self-citationFang, L., Holford, N. H. G., Hinkle, G. H., Cao, X., Xiao, J. J., Bloomston, M., Gibbs, S. T., Saif, O. H. A., Dalton, J. T., Chan, K. K., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006293758 · Cited by 32
Agnese, D. M., Abdessalam, S. F., Burak, W. E., ARNOLD, M. W., Soble, D., Hinkle, G. H., Young, D. C., Khazaeli, M. B., & Martin, E. W. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.05.010 · Cited by 32
Kjeldsen, T., Hakomori, S., Springer, G. F., Desai, P., Harris, T., & Clausen, H. (1989) · Vox Sanguinis · doi:10.1111/j.1423-0410.1989.tb04990.x · Cited by 31
Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
Morita, N., Yajima, Y., Asanuma, H., Nakada, H., & Fujita‐Yamaguchi, Y. (2009) · PubMed · Cited by 30
Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.
Vainchenker, W., VINCI, G., Testa, U., Henri, A., Tabilio, A., Fache, M., Rochant, H., & Cartron, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111730 · Cited by 28 · cited 1×
“In addition, the only iden-tified and specific molecular consequence of a loss of Cosmc in humans, such as Tn syndrome patients [78], as discussed below, is the loss of T-synthase activity and expression of the Tn antigen [78–85], and consequences of the lack of expression of the T-synthase.”
Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes
Göpfert, T., Gess, B., Eckardt, K., & Kurtz, A. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199608)168:2<284::aid-jcp7>3.0.co;2-l · Cited by 27 · cited 1×
“Some glycoproteins may have a single O-glycan, as is the case for the transferrin receptor [24–27], less than a few dozen O-glycans, as found in the LDL-receptor [28–31], many dozens, as found in PSGL-1 [32–34], or thousands, as found in epithelial mucins, such as MUC1 [35,36], MUC5B [37,38],…”
Phelan, C. M., Tsai, Y.-Y., Goode, E. L., Vierkant, R. A., Fridley, B. L., Beesley, J., Chen, X. Q., Webb, P. M., Chanock, S. J., Cramer, D. W., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0861 · Cited by 26
Rogers, B. E., Roberson, P. L., Shen, S., Khazaeli, M. B., Carpenter, M., Yokoyama, S., Brechbiel, M. W., LoBuglio, A. F., & Buchsbaum, D. J. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.502 · Cited by 25
Reepmaker, J. (1952) · Journal of Clinical Pathology · doi:10.1136/jcp.5.3.266 · Cited by 25 · cited 1×
“This enzyme transfers Gal from the donor UDP-Gal to synthesize the core 1 disaccharide Galβ1-3GalNAcα1-O-Ser/Thr, which is also called the T antigen (and is also sometimes called the Thomsen-Friedenreich or TF antigen) [50,51].”
Kato, K., Takeuchi, H., Kanoh, A., Miyahara, N., Nemoto‐Sasaki, Y., Morimoto‐Tomita, M., Matsubara, A., Ohashi, Y., Waki, M., Usami, K., et al. (2010) · Glycoconjugate Journal · doi:10.1007/s10719-009-9275-4 · Cited by 24
Kubota, T., Matsushita, T., Niwa, R., Kumagai, I., & Nakamura, K. (2010) · PubMed · Cited by 24
Imada, T., Rino, Y., Hatori, S., Takahashi, M. P., Amano, T., Kondo, J., & Suda, T. (1999) · PubMed · Cited by 23
Wu, S. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.569 · Cited by 22
Sun, Q., Ju, T., & Cummings, R. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173591 · Cited by 22 · cited 1×
“Cosmc is an ER-resident protein [69,70], retained there by its unique transmembrane domain, and exists as a disulfide bonded dimer via Cys residues in the trans-membrane domain [71].”
Self-citationIkeda, Y., Mori, M., Kamakura, T., Saku, M., & Sugimachi, K. (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(95)90369-0 · Cited by 21
Prognostic relevance of tn expression in Breast Cancer
Tsuchiya, A., Kanno, M., Kawaguchi, T., Endo, Y., Zhang, G., Ohtake, T., & Kimijima, I. (1999) · Breast Cancer · doi:10.1007/bf02967164 · Cited by 20 · cited 1×
“It has been estimated that the Tn antigen may be expressed in > 70% of human carcinomas, including colon [100], and others [101–105].”
Zou, P., Povoski, S. P., Hall, N. C., Carlton, M. M., Hinkle, G. H., Xu, R. X., Mojzisik, C. M., Johnson, M., Knopp, M. V., Martin, E. W., et al. (2010) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-8-65 · Cited by 20
Repressed β-1,3-galactosyltransferase in the Tn syndrome
Felner, K. M., Dinter, A., Cartron, J., & Berger, E. G. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00090-2 · Cited by 20
Guadagni, F., Roselli, M., Cosimelli, M., Spila, A., Cavaliere, F., TEDESCO, M., Arcuri, R., Abbolito, M. R., Casale, V., Pericoli, M. N., et al. (1996) · PubMed · Cited by 19
Filella, X., Molina, R., Jo, J., Bedini, J. L., Joseph, J., & Ballesta, A. M. (1992) · PubMed · Cited by 18
Narimatsu, Y., Ikehara, Y., Iwasaki, H., Nonomura, C., Sato, T., Nakanishi, H., & Narimatsu, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.121 · Cited by 18 · cited 1×
“Cosmc is an ER-resident protein [69,70], retained there”
Expression of Cellular Adhesion Proteins and Abnormal Glycoproteins in Human Aberrant Crypt Foci
Wargovich, M. J., Chang, P., Velasco, M. A. D., Sinicrope, F. A., Eisenbrodt, E., & Sellin, J. H. (2004) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200412000-00011 · Cited by 18 · cited 1×
“[117] found that CEA and STn were elevated in aberrant crypt foci (ACFs), which are the earliest recognizable histological precursor lesions for colon cancer.”
Muroi, K., Suda, T., Nakamura, M., Okada, S., Nojiri, H., Amemiya, Y., Miura, Y., & Hakomori, S. (1994) · Blood · doi:10.1182/blood.v83.1.84.bloodjournal83184 · Cited by 18
Construction and optimization of a CC49-Based scFv-β-lactamase fusion protein for ADEPT
Roberge, M., Estabrook, M., Basler, J., Chin, R., Gualfetti, P., Liu, A. Y., Wong, S. B., Rashid, M. H., Graycar, T., Babé, L. M., et al. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzj012 · Cited by 16
Berriel, E., Hill, M., Barcia, J. J., Ubillos, L., Gonzalez, M., Detjen, G., Rondán, M., Navarrete, H., & Osinaga, E. (2005) · PubMed · Cited by 13
Kawano-Yamamoto, C., Muroi, K., Nagatsuka, Y., Higuchi, M., Kikuchi, S., Nagai, T., Hakomori, S., & Ozawa, K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.10.021 · Cited by 13
Bolscher, J. G. M., Brevoord, J., Nazmi, K., Ju, T., Veerman, E. C. I., van Wijk, J. A. E., Cummings, R. D., & van Die, I. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.07.022 · Cited by 12 · cited 1×
“While such vaccine trials are encouraging, the design of the proper immunogens and conjugates continue to be major challenges in the field, as well as understanding the specific antibody recognition of Tn-containing antigens [177,183,202–207].”
Self-citationShen, S., Forero, A., Meredith, R. F., & LoBuglio, A. F. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0864 · Cited by 11 · cited 1×
“Although some studies showed that the antibody distributed mainly in the xenografts of human tumors in mice [178,196] and in human CRC [197], Sialyl T antigen is a normal O-glycan and reactivity to normal tissue is a major concern.”
Research works printed but not linked: 2
- [84]Ju T Otto VI Cummings RD The Tn antigen-structural simplicity and biological complexity Angew Chem Int Ed Engl 2011 50 8 1770 91 21259410 PMC7159538
- [87]Friedenreich V The Thomsen Hemagglutination Phenomenon: Production of a Specific Receptor Quality in Red Corpuscles by Bacterial Activity Dissertation Thesis Copenhagen Levin and Munksgaard 1930
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Disruption of this layer by genetically altering mucin backbones, O-linked glycosyltransferases (or key chaperones like Cosmc) can have very serious consequences, including inflammation and carcinogenesis associated with microbial invasion (453) (454) (455) (456) .”
BackgroundProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
“Once folded properly, the T-synthase moves to the Golgi apparatus, where it acts quantitatively on the products of the ppGalNAcTs to generate normal O-glycans (102).”
BackgroundInfluentialSelf-citationHallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
“Cancer cells characteristically express proteins with truncated O-glycan structures that are thought to be due to mutations or epigenetic silencing of the COSMC gene [95, 96], or to increased expression of ST6GalNAc1 [88].”
BackgroundSialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
Kudelka, M. R., Stowell, S. R., Cummings, R. D., & Neish, A. S. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0331-7 · Cited by 355
Self-citation
Metadata
- Authors
- Ju, T., Aryal, R. P., Kudelka, M. R., Wang, Y., & Cummings, R. D.
- Affiliations
- Emory University (US)
- Corresponding author
- Cummings, Richard D.
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2014-02-27
- Volume
- 14
- Issue
- 1
- Pages
- 63-81
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- PMC
- PMC5808877
- OpenAlex
- W1544375765
- Cited by
- 153
- References
- 202
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 11 · 2023: 22 · 2022: 14 · 2021: 14 · 2020: 18 · 2019: 14 · 2018: 10 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 2
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- Locations
- Cancer Biomarkers (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U01CA168930)
- National Institute of General Medical Sciences (T32GM008169, R24GM098791)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Tn antigen, sialyl-Tn antigen, Cosmc, T-synthase, O-glycosylation, tumor-associated carbohydrate antigens, X chromosome, molecular chaperones, protein misfolding, epigenetic regulation
- MeSH terms
- Animals, Carbohydrate Sequence, Glycosylation, Humans, Neoplasms, Polysaccharides, Antigens, Tumor-Associated, Carbohydrate, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.